Association between dexamethasone and thromboembolic events in the primary analysis
| Characteristic | Adjusted OR (95% CI) |
| Medications | |
| Dexamethasone | 1.2 (0.3 to 4.2) |
| Aspirin | 2.4 (1.4 to 4.0) |
| CYP3A4 inhibitor | 2.1 (0.9 to 5.1) |
| CYP3A4 inducer | 2.2 (0.4 to 14) |
| Antiplatelet | 1.0 (0.4 to 2.5) |
| Unfractionated heparin | 1.7 (0.6 to 4.8) |
| Low molecular weight heparin | 4.5 (1.9 to 10.7) |
| Conditions | |
| Diabetes | 0.6 (0.4 to 1.0) |
| Pulmonary | 0.8 (0.5 to 1.3) |
| Heart failure | 1.7 (1.1 to 2.8) |
| Atrial fibrillation | 0.9 (0.5 to 1.4) |
| Hypertension | 2.0 (1.0 to 3.9) |
| Cancer | 0.7 (0.5 to 1.2) |
| Smoker | 1.9 (0.9 to 4.3) |
| Obese | 0.4 (0.2 to 0.7) |
| Mild comorbidity | 0.7 (0.4 to 1.3) |
CYP3A4, cytochrome P450-3A4.